NAV
17.90(-0.14%)Fund Size (CR)
₹251.87Expense Ratio
2.66Scheme Type
Active FundValue Research
-
Min. investment
₹5,000Minimum Additional Investment
₹1,000Minimum SIP Investment
₹500Minimum Withdrawal
₹1,000Exit Load
0.5%Return Since Launch
13.15%
Basic Details
Scheme Manager
Animesh Singh
Bench Mark
NIFTY Healthcare TRI
Type
OPEN
Lumpsum Returns
| Period Invested For | ₹10,000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | July 22, 2026 | 10221.65 | 2.22% | - | 0.83% | 107/1007 |
| 1 Month | June 29, 2026 | 10394.31 | 3.94% | - | 2.27% | 256/1007 |
| 3 Month | April 29, 2026 | 11257.05 | 12.57% | - | 4.90% | 89/1007 |
| 6 Month | January 29, 2026 | 12364.63 | 23.65% | - | 7.09% | 55/968 |
| 1 Year | July 29, 2025 | 10624.16 | 6.24% | 6.24% | 6.92% | 403/904 |
| 3 Year | July 28, 2023 | 16432.45 | 64.32% | 17.97% | 15.43% | 167/548 |
| 5 Year | - | - | - | - | - | -/- |
| Since Inception | November 8, 2021 | 17925.50 | 79.25% | 13.15% | 12.05% | 496/1007 |
Note: Lumpsum Returns since Inception Date.
SIP Returns
| Period Invested For | ₹10,000 Invested on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | August 1, 2025 | 1,20,000 | 134889.11 | 12.41% | 12.41% |
| 3 Year | August 1, 2023 | 3,60,000 | 442565.48 | 22.93% | 7.13% |
| 5 Year | December 1, 2021 | 5,60,000 | 824040.24 | 47.15% | 8.03% |
| 10 Year | - | - | - | - | - |
Note: SIP Returns since Inception Date.
Tax Treatment
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 10%, if your total long term capital gain exceeds 1 lakh. Any cess/surcharge is not included.If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 15%. Any cess/surcharge is not included in the 15%.
Risk Ratios
4.79%
Standard Deviation
0.94%
Beta
0.81%
Sharpe Ratio
0.02%
Treynor's Ratio
-1.98%
Jension's Alpha
Asset Allocation
Sector Allocation
Top 10 stock holding in portfolio
| Stock Invested in | % of Total Holdings | Quantity | Value (Cr) | Asset Type | Segment |
|---|---|---|---|---|---|
| Sun Pharma.Inds. | 13.34% | 180398 | 33.60 | Equity | Pharmaceuticals |
| Divi's Lab. | 6.79% | 25990 | 17.10 | Equity | Pharmaceuticals |
| Apollo Hospitals | 6.22% | 18032 | 15.66 | Equity | Healthcare |
| Dr Reddy's Labs | 5.44% | 100879 | 13.69 | Equity | Pharmaceuticals |
| Max Healthcare | 5.41% | 120721 | 13.63 | Equity | Healthcare |
| Cipla | 4.60% | 79036 | 11.58 | Equity | Pharmaceuticals |
| Torrent Pharma. | 4.56% | 24834 | 11.47 | Equity | Pharmaceuticals |
| Laurus Labs | 4.40% | 73055 | 11.09 | Equity | Pharmaceuticals |
| Aurobindo Pharma | 4.10% | 65463 | 10.33 | Equity | Pharmaceuticals |
| Lupin | 3.30% | 34373 | 8.31 | Equity | Pharmaceuticals |
Peer Comparison
| Scheme Name | Value Research | Asset Size (Cr) | 1M | 3M | 6M | 1Y | 3Y |
|---|---|---|---|---|---|---|---|
| Nippon India Taiwan Equity Fund - Direct (G) | 1191.72 | -20.38% | -16.72% | 39.31% | 109.30% | 44.79% | |
| Nippon India Taiwan Equity Fund - Direct (IDCW) | 1191.72 | -20.38% | -16.72% | 39.31% | 109.30% | 44.79% | |
| Franklin Asian Equity Fund - Direct (G) | 979.21 | -6.15% | 3.35% | 8.47% | 33.77% | 17.71% | |
| Franklin Asian Equity Fund - Direct (IDCW) | 979.21 | -6.15% | 3.35% | 8.47% | 33.76% | 17.70% | |
| Nippon India Japan Equity Fund - Direct (G) | 332.11 | 0.99% | 5.49% | 14.88% | 33.45% | 19.18% |
List of Schemes under ITI Mutual Fund
News
ITI Mutual Fund announces Ceasation of Key Personnel
ITI Mutual Fund announces that Mr. Vikas Pandya shall cease to be the Head ' Compliance, Legal & Secretarial and Compliance Officer of ITI AMC with effect from the close of business hours on July 27, 2026.Powered by Capital Market - Live News
ITI Mutual Fund announces Appointment of Key Personnel
ITI Mutual Fund has announced that Mr. Dhruvkumar Trivedi has been appointed as an Acting Compliance Officer and Company Secretary for Mutual Fund business and is a Key Personnel at ITI Asset Management Ltd, with effect from July 27, 2026.Name: Mr. Dhruvkumar Trivedi,
Age: 33 years
Designation: Acting Compliance Officer and Company Secretary
Qualification: ACS, LLB
Powered by Capital Market - Live News
ITI Mutual Fund announces change in scheme name
ITI Mutual Fund has announced change in scheme name under the following scheme, with effect from July 10 2026.Changes in Scheme Name:
Existing Scheme Name Revised Scheme Name ITI Ultra Short Duration Fund ITI Ultra Short Term Fund ITI Dynamic Bond Fund ITI Dynamic Term Fund Powered by Capital Market - Live News
Fund House Details & Investment Objective
Date of Incorporation
October 18, 2021
Total AUM (Cr)
₹251.87
ITI Pharma and Healthcare Fund (G) is an Sectoral / Thematic-oriented fund from the renowned AMC, ITI Mutual Fund. Launched in October 18, 2021, this fund is managed by Animesh Singh. With assets under management (AUM) worth ₹251.87 (Cr), as of July 30, 2026, ITI Pharma and Healthcare Fund (G) is categorized as a Sectoral / Thematic within its segment. The fund has generated a return of 13.15% since its launch.
The current NAV of ITI Pharma and Healthcare Fund (G) is ₹17.9, as on July 30, 2026. The fund's benchmark index is NIFTY Healthcare TRI. You can invest in ITI Pharma and Healthcare Fund (G) via both lumpsum and SIP modes. The minimum SIP amount in the fund is ₹500 while the minimum lumpsum investment is ₹5,000.
Being an open-ended fund, you can exit the fund anytime subject to applicable exit loads:
The fund has generated 17.97% and undefined% CAGR in the last 3 and 5 years respectively.
The fund aims to provide long-term capital appreciation and growth, by investing in a mix of financial instruments 96.78% in Equity, 3.22% in cash and cash equivalents.
The top 5 sectors the fund invests in are: 71.33% in Pharmaceuticals & Biotech, 19.56% in Healthcare Services, 2.42% in Chemicals & Petrochemical, 2.00% in Cash & Others, 1.47% in Consumer Durables
Mutual Fund Categories
Types of Mutual Funds
Debt Funds
Access debt markets and enjoy interest income from bonds and debentures. Ideal for conservative short-term investors
Hybrid Funds
Enjoy best of both the worlds - equity and debt. Ideal for beginners with medium-term investment horizon
Equity Funds
Invest in large, mid, and small cap sector stocks to enjoy capital appreciation. Ideal for aggressive, long-term investors